A2 Corp, which markets milk products with a protein variant claimed to have health benefits, had its shares halted from trading pending a statement.
The Sydney-based company, whose shares have more than doubled in the past 12 months, said last week it is in talks with the NZX about shifting its listing to the main board from the NZAX, a market for smaller companies and start-ups.
The shares traded at 67 cents yesterday, valuing the company at $399 million.
"A move to the NZX main board may provide greater liquidity and increase access to capital," managing director Geoffrey Babidge said last week.
Last month, the company completed a six-month strategic review and has embarked on plans to take control of its New Zealand marketing and accelerate its global expansion.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Loss of Premier League rights reveals limit to Spark's on-demand video ambition
- Behold Fanpass, Sky's streaming video service that actually works – and today it's free
- Blame the architects for the building my company is about to destroy
- Awaroa owner's debt stoush raises crowdfunding profile
- Affco must allow workers to return to day shifts, Employment Court rules
Most listened to
- Sir Bob Jones on the state of New Zealand architecture
- ForBarr analyst Blair Galpin on the Premier League development - and the future of sports broadcasting as technology shifts
- Macquarie's Brad Gordon on Michael Hill's "very good" results
- Nevil Gibson on whether we've seen the end of El Nino in his latest Editor's Insight
- RNZ chief executive Paul Thompson on what it means to be included in the commercial radio survey